Form 4 Tracker
Larimar Therapeutics, Inc.
LRMR

14 insider filings · Latest: May 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 27, 2026Mar 3 12:46 AMJames E FlynnDirector, 10% Owner, Other
Purchase
5,000,000$5.00$25.0M6,207,982(I)

View →

Feb 27, 2026Mar 2 9:30 PMThomas Edward HamiltonDirector
Purchase
100,000$5.00$500.0K664,798(D)

View →

Feb 27, 2026Mar 2 9:30 PMFrank E ThomasDirector
Purchase
5,000$5.00$25.0K7,000(D)

View →

Feb 27, 2026Mar 2 9:30 PMJeffrey W ShermanDirector
Purchase
5,000$5.00$25.0K5,000(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 19, 2026May 21 12:02 AMJames E FlynnDirector, 10% Owner, Other
Grant/Award
55,150$3.3355,150(I)

View →

May 19, 2026May 20 10:03 PMJonathan S LeffDirector
Grant/Award
55,150$3.3355,150(D)

View →

May 19, 2026May 20 8:30 PMJeffrey W ShermanDirector
Grant/Award
55,150$3.3355,150(D)

View →

May 19, 2026May 20 8:28 PMJoseph TruittDirector
Grant/Award
55,150$3.3355,150(D)

View →

May 19, 2026May 20 8:24 PMFrank E ThomasDirector
Grant/Award
55,150$3.3355,150(D)

View →

May 19, 2026May 20 8:21 PMThomas Edward HamiltonDirector
Grant/Award
55,150$3.3355,150(D)

View →

Jan 26, 2026Jan 27 10:04 PMGopi ShankarChief Development Officer
Grant/Award
153,822$3.60153,822(D)

View →

Jan 26, 2026Jan 27 10:04 PMRussell ClaytonChief Medical Officer
Grant/Award
153,822$3.60153,822(D)

View →

Jan 26, 2026Jan 27 10:04 PMCarole Ben-MaimonDirector, President and CEO
Grant/Award
600,600$3.60600,600(D)

View →

Jan 26, 2026Jan 27 10:03 PMMichael CelanoChief Financial Officer
Grant/Award
225,622$3.60225,622(D)

View →